These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 2224848
1. Effect of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro. Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT. Cancer Res; 1990 Nov 15; 50(22):7134-8. PubMed ID: 2224848 [Abstract] [Full Text] [Related]
2. Response of malignant glioma cell lines to activation and inhibition of protein kinase C-mediated pathways. Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT. J Neurosurg; 1990 Jul 15; 73(1):98-105. PubMed ID: 2161913 [Abstract] [Full Text] [Related]
3. Tamoxifen interacts with NEU/C-ERBB-2 receptor and inhibits growth of human malignant glioma cell lines. Liu Z, Kokunai T, Tamaki N. Kobe J Med Sci; 2001 Jun 15; 47(3):131-40. PubMed ID: 11729374 [Abstract] [Full Text] [Related]
4. A phase I study of high-dose tamoxifen for the treatment of refractory malignant gliomas of childhood. Pollack IF, DaRosso RC, Robertson PL, Jakacki RL, Mirro JR, Blatt J, Nicholson S, Packer RJ, Allen JC, Cisneros A, Jordan VC. Clin Cancer Res; 1997 Jul 15; 3(7):1109-15. PubMed ID: 9815790 [Abstract] [Full Text] [Related]
5. Coadministration of sorafenib with rottlerin potently inhibits cell proliferation and migration in human malignant glioma cells. Jane EP, Premkumar DR, Pollack IF. J Pharmacol Exp Ther; 2006 Dec 15; 319(3):1070-80. PubMed ID: 16959960 [Abstract] [Full Text] [Related]
6. The efficacy of tamoxifen as an antiproliferative agent in vitro for benign and malignant pediatric glial tumors. Pollack IF, Kawecki S. Pediatr Neurosurg; 1995 Dec 15; 22(6):281-8. PubMed ID: 7577661 [Abstract] [Full Text] [Related]
8. Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells. Hui AM, Zhang W, Chen W, Xi D, Purow B, Friedman GC, Fine HA. Cancer Res; 2004 Dec 15; 64(24):9115-23. PubMed ID: 15604281 [Abstract] [Full Text] [Related]
9. Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine. Strobl JS, Kirkwood KL, Lantz TK, Lewine MA, Peterson VA, Worley JF. Cancer Res; 1990 Sep 01; 50(17):5399-405. PubMed ID: 2386945 [Abstract] [Full Text] [Related]
10. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro. Reddel RR, Sutherland RL. Cancer Res; 1987 Oct 15; 47(20):5323-9. PubMed ID: 3652038 [Abstract] [Full Text] [Related]
14. Drug and hormone sensitivity of estrogen receptor-positive and -negative human breast cancer cells in vitro. Goldenberg GJ, Froese EK. Cancer Res; 1982 Dec 15; 42(12):5147-51. PubMed ID: 7139616 [Abstract] [Full Text] [Related]
15. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. Laterra J, Nam M, Rosen E, Rao JS, Lamszus K, Goldberg ID, Johnston P. Lab Invest; 1997 Apr 15; 76(4):565-77. PubMed ID: 9111517 [Abstract] [Full Text] [Related]
16. Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice. Brünner N, Bronzert D, Vindeløv LL, Rygaard K, Spang-Thomsen M, Lippman ME. Cancer Res; 1989 Mar 15; 49(6):1515-20. PubMed ID: 2924304 [Abstract] [Full Text] [Related]
17. Estrogen receptor and hormone responsiveness of medullary thyroid carcinoma cells in continuous culture. Yang K, Pearson CE, Samaan NA. Cancer Res; 1988 May 15; 48(10):2760-3. PubMed ID: 3359436 [Abstract] [Full Text] [Related]
18. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells. Menendez JA, Oza BP, Atlas E, Verma VA, Mehmi I, Lupu R. Oncogene; 2004 Jun 17; 23(28):4945-58. PubMed ID: 15094777 [Abstract] [Full Text] [Related]
19. Paradoxical elevation of Ki-67 labeling with protein kinase inhibition in malignant gliomas. Couldwell WT, Weiss MH, Law RE, Hinton DR. J Neurosurg; 1995 Mar 17; 82(3):461-8. PubMed ID: 7861225 [Abstract] [Full Text] [Related]
20. K252a inhibits proliferation of glioma cells by blocking platelet-derived growth factor signal transduction. Chin LS, Murray SF, Zitnay KM, Rami B. Clin Cancer Res; 1997 May 17; 3(5):771-6. PubMed ID: 9815748 [Abstract] [Full Text] [Related] Page: [Next] [New Search]